Yamagishi J, Kojima T, Oyamada Y, Fujimoto K, Hattori H, Nakamura S, Inoue M
Discovery Research Laboratories II, Dainippon Pharmaceutical Co., Ltd., Suita, Osaka, Japan.
Antimicrob Agents Chemother. 1996 May;40(5):1157-63. doi: 10.1128/AAC.40.5.1157.
A 4.2-kb DNA fragment conferring quinolone resistance was cloned from a quinolone-resistant clinical isolate of Staphylococcus aureus and was shown to possess a part of the grlB gene and a mutated grlA gene. S-80-->F and E-84-->K mutations in the grlA gene product were responsible for the quinolone resistance. The mutated grlA genes responsible for quinolone resistance were dominant over the wild-type allele, irrespective of gene dosage in a transformation experiment with the grlA gene alone. However, dominance by mutated grlA genes depended on gene dosage when bacteria were transformed with the grlA and grlB genes in combination. Quinolone-resistant gyrA mutants were easily isolated from a strain, S. aureus RN4220, carrying a plasmid with the mutated grlA gene, though this was not the case for other S. aureus strains lacking the plasmid. The elimination of this plasmid from such quinolone-resistant gyrA mutants resulted in marked increases in quinolone susceptibility. These results suggest that both DNA gyrase and DNA topoisomerase IV may be targets of quinolones and that the quinolone susceptibility of organisms may be determined by which of these enzymes is most quinolone sensitive.
从一株耐喹诺酮的金黄色葡萄球菌临床分离株中克隆出一段赋予喹诺酮抗性的4.2 kb DNA片段,该片段含有部分grlB基因和一个突变的grlA基因。grlA基因产物中的S-80→F和E-84→K突变导致了喹诺酮抗性。在仅用grlA基因进行的转化实验中,无论基因剂量如何,导致喹诺酮抗性的突变grlA基因均对野生型等位基因呈显性。然而,当细菌用grlA和grlB基因联合转化时,突变grlA基因的显性取决于基因剂量。耐喹诺酮的gyrA突变体很容易从携带突变grlA基因质粒的金黄色葡萄球菌RN4220菌株中分离出来,而对于其他缺乏该质粒的金黄色葡萄球菌菌株则并非如此。从这些耐喹诺酮的gyrA突变体中消除该质粒会导致喹诺酮敏感性显著增加。这些结果表明,DNA回旋酶和DNA拓扑异构酶IV可能都是喹诺酮的作用靶点,生物体对喹诺酮的敏感性可能由这些酶中对喹诺酮最敏感的酶决定。